|
Market Closed -
Nasdaq
07:00:00 09/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 35.45 USD | -1.88% |
|
+0.20% | -1.20% |
| Market Cap | 4.18B 3.74B 3.49B 3.17B 5.96B 405B 6.02B 41.84B 16.37B 206B 15.71B 15.37B 662B | P/E 2026 * |
9.53x | P/E 2027 * | 8.64x |
|---|---|---|---|---|---|
| Enterprise Value | 4.17B 3.72B 3.47B 3.16B 5.94B 404B 6B 41.72B 16.32B 205B 15.66B 15.32B 660B | EV / Sales 2026 * |
3.13x | EV / Sales 2027 * | 2.58x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INDV | Delayed | |
CBOE
| INDV | Real-time | |
|
Xetra
| E7P | Delayed | |
|
Deutsche Boerse AG
| E7P | Delayed | |
|
Boerse Muenchen
| E7P | Real-time | |
|
Tradegate
| E7P | Real-time |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -1.88% | ||
| 1 week | +0.20% | ||
| Current month | -1.12% | ||
| 1 month | +3.29% | ||
| 3 months | -13.30% | ||
| 6 months | +10.99% | ||
| Current year | -1.20% |
| 1 week | 34.85 |  | 36.35 |
| 1 month | 33.74 | | 37.05 |
| Current year | 27.68 | | 42.81 |
| 1 year | 22.95 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/8/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 5/8/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 10/7/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.88% | +0.20% | +47.28% | +68.89% | 4.18B | |
| -1.61% | +1.72% | +38.30% | +106.93% | 1,043B | |
| -0.76% | -0.84% | +35.21% | +62.70% | 618B | |
| +0.39% | +4.81% | +17.81% | +83.77% | 481B | |
| -0.29% | -0.99% | +64.79% | +37.06% | 351B | |
| +1.55% | +3.64% | +22.04% | +42.83% | 338B | |
| +0.93% | +2.37% | +11.71% | +35.14% | 269B | |
| +1.38% | +1.77% | -6.65% | +11.27% | 244B | |
| -1.37% | +0.04% | +38.29% | +52.33% | 220B | |
| +0.17% | -0.27% | +24.40% | +96.82% | 182B | |
| Average | +0.04% | +0.27% | +29.32% | +59.77% | 375.09B | |
| Weighted average by Cap. | +0.06% | +0.60% | +30.68% | +69.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33B 1.19B 1.11B 1.01B 1.9B 129B 1.92B 13.32B 5.21B 65.55B 5B 4.89B 211B | 1.4B 1.25B 1.17B 1.06B 1.99B 136B 2.01B 14B 5.47B 68.88B 5.25B 5.14B 222B |
| Net income | 474M 424M 395M 359M 675M 45.93B 682M 4.74B 1.86B 23.34B 1.78B 1.74B 75.07B | 530M 473M 441M 401M 755M 51.33B 762M 5.3B 2.07B 26.08B 1.99B 1.95B 83.88B |
| Net Debt | -12.5M -11.16M -10.41M -9.46M -17.8M -1.21B -17.97M -125M -48.9M -615M -46.93M -45.91M -1.98B | -570M -509M -475M -431M -812M -55.2B -820M -5.7B -2.23B -28.05B -2.14B -2.09B -90.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/10/26 | USD 35.45 | -1.88% | 1,527,166 |
| 07/10/26 | USD 36.13 | +0.64% | 1,769,649 |
| 06/10/26 | USD 35.90 | -0.25% | 2,390,574 |
| 05/10/26 | USD 35.99 | +0.78% | 3,003,290 |
| 02/10/26 | USD 35.71 | +0.93% | 1,669,266 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
